Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03850808 · ClinicalTrials.gov registry record

LV Dysfunction Following Pacemaker Placement

A clinical trial, sponsored by Oregon Health and Science University.

Completed
Registry status
500
Enrollment target

NCT03850808 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 500 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03850808 has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
500 participants
Enrollment target

Study Summary

Several studies have confirmed the link between chronic RV apical pacing and the development of heart failure and LV systolic dysfunction in some patients 1,2. However, questions continue to remain unanswered in regard to the adverse effects of RV pacing such as the exact amount of RV pacing that is detrimental to cardiac function and which subsets of patients are most at risk for developing cardiac dysfunction from chronic RV pacing. Rates of permanent pacemaker implantation have been increased over the last twenty years with expanding indications to include permanent pacing after AV node ablation for the treatment of drug refractory atrial fibrillation and other atrial tachy-arrhythmias. The current standard of practice is to minimize RV pacing however in patients that have had an AV node ablation right ventricular pacing cannot be avoided therefore it is important to identify if this particular group of patients is at an increased risk for developing worsening cardiac function. The purpose of this study is to compare cardiac function over time between patients that have undergone AV node ablation versus patients that have had pacemaker implantation for AV node dysfunction.

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2013-09
Est. Completion 2018-09

What the Registry Record Tells You About NCT03850808

The ClinicalTrials.gov registry entry for NCT03850808 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03850808 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03850808 about?

NCT03850808 is a clinical study titled "LV Dysfunction Following Pacemaker Placement". Several studies have confirmed the link between chronic RV apical pacing and the development of heart failure and LV systolic dysfunction in some patients 1,2. However, questions continue to remain unanswered in regard to the adverse effects of RV pacing such as the exact amount of RV pacing that is...

What is the current status of trial NCT03850808?

This trial is currently completed. The enrollment target is 500 participants. The study started on 2013-09. Estimated completion is 2018-09.

Who is sponsoring clinical trial NCT03850808?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.